Home
SCNI
SCNI News

Latest Scinai Immunotherapeutics Ltd. (SCNI) News on September 4, 2025

Scinai Highlights Award-Winning Science Behind PC111 as Key Pincell Researcher Receives "Oscar of Italian Dermatology"

PR Newswire

2 months ago

Scinai Highlights Award-Winning Science Behind PC111 as Key Pincell Researcher Receives "Oscar of Italian Dermatology"

Scinai Highlights New Funding and CDMO Growth Ahead of BIO International Convention 2025

PR Newswire

3 months ago

Scinai Highlights New Funding and CDMO Growth Ahead of BIO International Convention 2025

Scinai Immunotherapeutics Receives Italian Government Clearance Under Golden Power Regulation for Potential Acquisition of Pincell S.r.l.

PR Newswire

3 months ago

Scinai Immunotherapeutics Receives Italian Government Clearance Under Golden Power Regulation for Potential Acquisition of Pincell S.r.l.

Scinai Reports Q1 2025 Financial Results Highlighting Strong CDMO Revenue Momentum and Reduced Cash Burn

PR Newswire

3 months ago

Scinai Reports Q1 2025 Financial Results Highlighting Strong CDMO Revenue Momentum and Reduced Cash Burn

Scinai Announces Annual Financial Results for 2024

PR Newswire

4 months ago

Scinai Announces Annual Financial Results for 2024

Scinai Immunotherapeutics and Pincell to Host Webinar on a Blockbuster Drug Candidate for Devastating Rare Skin Diseases

PR Newswire

4 months ago

Scinai Immunotherapeutics and Pincell to Host Webinar on a Blockbuster Drug Candidate for Devastating Rare Skin Diseases

Scinai signs an option agreement to acquire rare disease company Pincell and its novel antibody for treating Severe Dermatological Conditions

PR Newswire

5 months ago

Scinai signs an option agreement to acquire rare disease company Pincell and its novel antibody for treating Severe Dermatological Conditions

Scinai to Connect with Investors, Showcase its Innovative I&I pipeline and its Boutique cGMP Biologics CDMO during BIO-Europe Spring 2025

PR Newswire

6 months ago

Scinai to Connect with Investors, Showcase its Innovative I&I pipeline and its Boutique cGMP Biologics CDMO during BIO-Europe Spring 2025

SCINAI IMMUNOTHERAPEUTICS ANNOUNCES $10 MILLION STANDBY EQUITY PURCHASE AGREEMENT

PR Newswire

6 months ago

SCINAI IMMUNOTHERAPEUTICS ANNOUNCES $10 MILLION STANDBY EQUITY PURCHASE AGREEMENT

Scinai to Connect with Investors and Pharma Leaders at Upcoming Key US Conferences

PR Newswire

8 months ago

Scinai to Connect with Investors and Pharma Leaders at Upcoming Key US Conferences

Scinai Immunotherapeutics Establishes U.S. Subsidiary for CDMO Business Unit, Scinai Bioservices Inc.

PR Newswire

9 months ago

Scinai Immunotherapeutics Establishes U.S. Subsidiary for CDMO Business Unit, Scinai Bioservices Inc.

Prof. Michael Schön, Director of Dermatology and Venereology at the University Medical Center Göttingen, Germany (UMG), Joins Scinai Immunotherapeutics' Scientific Advisory Board

PR Newswire

9 months ago

Prof. Michael Schön, Director of Dermatology and Venereology at the University Medical Center Göttingen, Germany (UMG), Joins Scinai Immunotherapeutics' Scientific Advisory Board

There Are Some Reasons To Suggest That Scinai Immunotherapeutics' (NASDAQ:SCNI) Earnings Are A Poor Reflection Of Profitability

Simply Wall St.

9 months ago

There Are Some Reasons To Suggest That Scinai Immunotherapeutics' (NASDAQ:SCNI) Earnings Are A Poor Reflection Of Profitability

Dr. Jonathan Sadeh, Former Senior Vice President of Immunology R&D at Bristol-Myers Squibb, Joins Scinai Immunotherapeutics' Scientific Advisory Board

PR Newswire

9 months ago

Dr. Jonathan Sadeh, Former Senior Vice President of Immunology R&D at Bristol-Myers Squibb, Joins Scinai Immunotherapeutics' Scientific Advisory Board

Scinai Publishes Financial Results and Provides Business Update; Shareholders' Equity up from negative $7.3 million as of June 30, 2024, to positive $10 million

PR Newswire

9 months ago

Scinai Publishes Financial Results and Provides Business Update; Shareholders' Equity up from negative $7.3 million as of June 30, 2024, to positive $10 million

Scinai Leadership to Showcase Company's cGMP Biologics CDMO and Innovative I&I pipeline during BIO-Europe 2024

PR Newswire

10 months ago

Scinai Leadership to Showcase Company's cGMP Biologics CDMO and Innovative I&I pipeline during BIO-Europe 2024

Scinai to Host Online Expert Panel on Plaque Psoriasis Treatment and Intralesional Injections of anti-IL-17A/F VHH Antibodies

PR Newswire

a year ago

Scinai to Host Online Expert Panel on Plaque Psoriasis Treatment and Intralesional Injections of anti-IL-17A/F VHH Antibodies

Scinai Regains Full Compliance with Nasdaq Listing Requirements

PR Newswire

a year ago

Scinai Regains Full Compliance with Nasdaq Listing Requirements

Scinai Announces Closing of Loan Restructuring Agreement with European Investment Bank Converting Approximately $29 million of Debt to Preferred Equity and Leaving Debt Balance of $273,000

PR Newswire

a year ago

Scinai Announces Closing of Loan Restructuring Agreement with European Investment Bank Converting Approximately $29 million of Debt to Preferred Equity and Leaving Debt Balance of $273,000

Scinai Announces Entering into $2 Million Private Equity Commitment Agreement with its largest Existing Shareholder

PR Newswire

a year ago

Scinai Announces Entering into $2 Million Private Equity Commitment Agreement with its largest Existing Shareholder

Scinai Publishes Q2 2024 Financial Results and Provides Business Update; Restructures $29 Million Bank Loan to Equity; On Track to Regain Nasdaq Compliance by August 23

PR Newswire

a year ago

Scinai Publishes Q2 2024 Financial Results and Provides Business Update; Restructures $29 Million Bank Loan to Equity; On Track to Regain Nasdaq Compliance by August 23

Scinai Announces Signing of Loan Restructuring Agreement with European Investment Bank; Converting Approximately $29 million of Debt to Preferred Equity Convertible into 19.5% Common Equity

PR Newswire

a year ago

Scinai Announces Signing of Loan Restructuring Agreement with European Investment Bank; Converting Approximately $29 million of Debt to Preferred Equity Convertible into 19.5% Common Equity

Scinai Immunotherapeutics Announces Positive Regulatory Feedback from the PEI on the path for Phase 1/2a in Plaque Psoriasis with its anti-IL-17 nanoAb

PR Newswire

a year ago

Scinai Immunotherapeutics Announces Positive Regulatory Feedback from the PEI on the path for Phase 1/2a in Plaque Psoriasis with its anti-IL-17 nanoAb

Scinai Immunotherapeutics Announces promising results in an in-vivo proof-of-concept psoriatic human skin model

PR Newswire

a year ago

Scinai Immunotherapeutics Announces promising results in an in-vivo proof-of-concept psoriatic human skin model

Scinai Immunotherapeutics Announces Receipt of an Updated Letter of Intent from the European Investment Bank Providing Specific Terms for Conversion of its Loan to Equity

PR Newswire

a year ago

Scinai Immunotherapeutics Announces Receipt of an Updated Letter of Intent from the European Investment Bank Providing Specific Terms for Conversion of its Loan to Equity

Scinai Immunotherapeutics Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements

PR Newswire

a year ago

Scinai Immunotherapeutics Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements

Scinai Publishes Q1 2024 Financial Results and Provides Business Update

PR Newswire

a year ago

Scinai Publishes Q1 2024 Financial Results and Provides Business Update

Scinai Immunotherapeutics Announces Receipt of a Letter of Intent from the European Investment Bank Providing Specific Terms for Conversion of its Loan to Equity.

PR Newswire

a year ago

Scinai Immunotherapeutics Announces Receipt of a Letter of Intent from the European Investment Bank Providing Specific Terms for Conversion of its Loan to Equity.

Start Proud Opens the Market

CNW Group

a year ago

Start Proud Opens the Market

Will recreational pot go on sale soon in Ohio? Medical marijuana stores can now apply to sell it

Associated Press Finance

a year ago

Will recreational pot go on sale soon in Ohio? Medical marijuana stores can now apply to sell it

Business Wire

a year ago

Form 8.3 - Darktrace plc

Dow Jones Trims Losses As Yields Spike On Jobs Data; GameStop Dives

Investor's Business Daily

a year ago

Dow Jones Trims Losses As Yields Spike On Jobs Data; GameStop Dives

May jobs reports signals Fed's soft landing: US Labor Secretary

Yahoo Finance Video

a year ago

May jobs reports signals Fed's soft landing: US Labor Secretary

Notification of major holding in Kindred Group plc

PR Newswire

a year ago

Notification of major holding in Kindred Group plc

NICE to Webcast Financial Analyst and Investor Day at Interactions 2024

Business Wire

a year ago

NICE to Webcast Financial Analyst and Investor Day at Interactions 2024

Business Wire

a year ago

Form 8.3 - DS Smith plc

Scinai Immunotherapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement; Continues to Work with the European Investment Bank to Convert Loan to Equity to Regain Compliance with Nasdaq Minimum Shareholders' Equity Requirement

PR Newswire

a year ago

Scinai Immunotherapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement; Continues to Work with the European Investment Bank to Convert Loan to Equity to Regain Compliance with Nasdaq Minimum Shareholders' Equity Requirement

Scinai Immunotherapeutics Announces Receipt of a Nasdaq Staff Determination Letter Regarding Shareholders' Equity listing requirements and Hearing to Present a Plan for Regaining Compliance

PR Newswire

a year ago

Scinai Immunotherapeutics Announces Receipt of a Nasdaq Staff Determination Letter Regarding Shareholders' Equity listing requirements and Hearing to Present a Plan for Regaining Compliance

Scinai Publishes FY 2023 Financial Statements, Files Annual Report on Form 20-F and Provides Business Update

PR Newswire

a year ago

Scinai Publishes FY 2023 Financial Statements, Files Annual Report on Form 20-F and Provides Business Update

Scinai Immunotherapeutics Announces Receipt of Nasdaq Delisting Notification and Appeal

PR Newswire

a year ago

Scinai Immunotherapeutics Announces Receipt of Nasdaq Delisting Notification and Appeal

Scinai to showcase its novel biological local therapeutic for Plaque Psoriasis at Dermatology Drug Development Summit together with Prof. Michael Schön of UMG

PR Newswire

a year ago

Scinai to showcase its novel biological local therapeutic for Plaque Psoriasis at Dermatology Drug Development Summit together with Prof. Michael Schön of UMG

Scinai Immunotherapeutics' CDMO Unit Selected by Ayana Pharma to Provide Drug Development and cGMP Manufacturing Services

PR Newswire

a year ago

Scinai Immunotherapeutics' CDMO Unit Selected by Ayana Pharma to Provide Drug Development and cGMP Manufacturing Services

Scinai leadership to attend BIO-Europe Spring 2024

PR Newswire

a year ago

Scinai leadership to attend BIO-Europe Spring 2024

Scinai to showcase its cGMP biologics CDMO and innovative NanoAb pipeline at MIXiii 2024

PR Newswire

2 years ago

Scinai to showcase its cGMP biologics CDMO and innovative NanoAb pipeline at MIXiii 2024

Scinai Welcomes Liat Halpert as Head of Business Development and Sales

PR Newswire

2 years ago

Scinai Welcomes Liat Halpert as Head of Business Development and Sales

GlobeNewswire

2 years ago

WiMi Developed Holographic Eye-Tracking Focusing System

GlobeNewswire

2 years ago

WiMi Developed An AI-driven Real-time Spatial Interaction Perception System for Interior Design

Scinai Immunotherapeutics Congratulates its Co-Lead Scientific Research Collaborator Dirk Görlich on Louis-Jeantet Prize

PR Newswire

2 years ago

Scinai Immunotherapeutics Congratulates its Co-Lead Scientific Research Collaborator Dirk Görlich on Louis-Jeantet Prize

Dog Study Published in PLOS ONE Shows Statistically Significant Results for Use of Jaguar Health’s Crofelemer for Preventive Treatment of Cancer Therapy-Related Diarrhea (CTD)

ACCESSWIRE

2 years ago

Dog Study Published in PLOS ONE Shows Statistically Significant Results for Use of Jaguar Health’s Crofelemer for Preventive Treatment of Cancer Therapy-Related Diarrhea (CTD)

GlobeNewswire

2 years ago

WiMi Developed Interactive System Based on V-BCI Technology Incorporated into Holographic Glasses

GlobeNewswire

2 years ago

WiMi Developed an LSTM-based Data Analysis System

GlobeNewswire

2 years ago

WiMi Developed a Trimmed K-Means Algorithm to Detect Crypto Wallet Fraud on the Bitcoin Network

22nd Century Group Provides Shareholder Update and Highlights Insider Stock Purchases from Management

Newsfile

2 years ago

22nd Century Group Provides Shareholder Update and Highlights Insider Stock Purchases from Management

GlobeNewswire

2 years ago

WiMi is Working on a New Mixed Byzantine Fault Tolerant (MBFT) Algorithm to Enhance Blockchain Fault Tolerance

GlobeNewswire

2 years ago

WiMi is Working on the Blockchain Secure Storage Strategy Based on the MCMC Algorithm

GlobeNewswire

2 years ago

WiMi is Working on the Optimization of a Blockchain Hashing Algorithm Based on PRCA

Investors Should Be Encouraged By Direct Digital Holdings' (NASDAQ:DRCT) Returns On Capital

Simply Wall St.

2 years ago

Investors Should Be Encouraged By Direct Digital Holdings' (NASDAQ:DRCT) Returns On Capital

Scinai Immunotherapeutics Announces Closing of Exercise of Outstanding Warrants for $1.69 Million in Gross Proceeds

PR Newswire

2 years ago

Scinai Immunotherapeutics Announces Closing of Exercise of Outstanding Warrants for $1.69 Million in Gross Proceeds

Scinai Immunotherapeutics CEO Issues Letter to Shareholders

PR Newswire

2 years ago

Scinai Immunotherapeutics CEO Issues Letter to Shareholders

Exela Technologies Announces Adjournment of Annual Meeting until January 26, 2024

GlobeNewswire

2 years ago

Exela Technologies Announces Adjournment of Annual Meeting until January 26, 2024

Scinai Immunotherapeutics Announces Exercise of Outstanding Warrants for $1.69 Million in Gross Proceeds

PR Newswire

2 years ago

Scinai Immunotherapeutics Announces Exercise of Outstanding Warrants for $1.69 Million in Gross Proceeds

Trevena Announces the Closing of $4 Million Concurrent Private Placement and Warrant Exercise

GlobeNewswire

2 years ago

Trevena Announces the Closing of $4 Million Concurrent Private Placement and Warrant Exercise

Society Pass Inc. (Nasdaq: SOPA): Litchfield Hills Initiates Equity Research Coverage; SOPA Growing Rapidly and Nearing Positive EBITDA Inflection

GlobeNewswire

2 years ago

Society Pass Inc. (Nasdaq: SOPA): Litchfield Hills Initiates Equity Research Coverage; SOPA Growing Rapidly and Nearing Positive EBITDA Inflection

Scinai (NASDAQ: SCNI) to Host Analyst and Investor Webinar on January 9

PR Newswire

2 years ago

Scinai (NASDAQ: SCNI) to Host Analyst and Investor Webinar on January 9

Streamline Health Solutions Third Quarter 2024 Earnings: Misses Expectations

Simply Wall St.

2 years ago

Streamline Health Solutions Third Quarter 2024 Earnings: Misses Expectations

Amtech (NASDAQ:ASYS) Reports Weak Q4

StockStory

2 years ago

Amtech (NASDAQ:ASYS) Reports Weak Q4

Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024

GlobeNewswire

2 years ago

Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024

Rain Oncology Enters into Agreement to be Acquired by Pathos AI for $1.16 in Cash per Share Plus Contingent Value Rights

GlobeNewswire

2 years ago

Rain Oncology Enters into Agreement to be Acquired by Pathos AI for $1.16 in Cash per Share Plus Contingent Value Rights

Scinai Announces Promising Results in a Psoriatic Human Skin Model

PR Newswire

2 years ago

Scinai Announces Promising Results in a Psoriatic Human Skin Model

Study published in Antiviral Research supports promise of Scinai Immunotherapeutics' coronavirus NanoAb as aerosolized prophylactic and therapeutic drug

PR Newswire

2 years ago

Study published in Antiviral Research supports promise of Scinai Immunotherapeutics' coronavirus NanoAb as aerosolized prophylactic and therapeutic drug

CNW Group

2 years ago

GREENBROOK TMS RAISES US$2.5 MILLION IN DEBT FINANCING

European Investment Bank (EIB) extends maturity of its finance facility with Scinai Immunotherapeutics from 2027 to 2031

PR Newswire

2 years ago

European Investment Bank (EIB) extends maturity of its finance facility with Scinai Immunotherapeutics from 2027 to 2031

Greenbrook TMS Announces Settlement of Ongoing Litigation

CNW Group

2 years ago

Greenbrook TMS Announces Settlement of Ongoing Litigation

Zacks Small Cap Research

2 years ago

HTCR: HeartCore reports 3rd quarter financial results that showed strong core revenue growth.

Lucid Diagnostics Inc. (NASDAQ:LUCD) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Lucid Diagnostics Inc. (NASDAQ:LUCD) Q3 2023 Earnings Call Transcript

Market Cool On HeartCore Enterprises, Inc.'s (NASDAQ:HTCR) Revenues Pushing Shares 46% Lower

Simply Wall St.

2 years ago

Market Cool On HeartCore Enterprises, Inc.'s (NASDAQ:HTCR) Revenues Pushing Shares 46% Lower

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Intrusion Inc Earnings Call

Insider Sell: Acme United Corp's President and COO Brian Olschan Sells 5,000 Shares

GuruFocus.com

2 years ago

Insider Sell: Acme United Corp's President and COO Brian Olschan Sells 5,000 Shares

ACCESSWIRE

2 years ago

MGO Global Announces Third Quarter 2023 Financial Results

Intrusion, Inc. Reports Third Quarter 2023 Results

ACCESSWIRE

2 years ago

Intrusion, Inc. Reports Third Quarter 2023 Results

Sidoti Events, LLC’s Virtual November Micro-Cap Conference

ACCESSWIRE

2 years ago

Sidoti Events, LLC’s Virtual November Micro-Cap Conference

Ironwood's (IRWD) Q3 Earnings Miss Mark, Linzess Volume Rises

Zacks

2 years ago

Ironwood's (IRWD) Q3 Earnings Miss Mark, Linzess Volume Rises

FTC Solar, Inc. (NASDAQ:FTCI) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

FTC Solar, Inc. (NASDAQ:FTCI) Q3 2023 Earnings Call Transcript

Associated Press Finance

2 years ago

Personalis: Q3 Earnings Snapshot

ACCESSWIRE

2 years ago

MGO Global to Host Third Quarter 2023 Financial Results Webcast on Tuesday, November 14, 2023 at 4:30 PM ET

PolyPid Announces the Addition of Dr. Nurit Tweezer-Zaks to its Board of Directors

GlobeNewswire

2 years ago

PolyPid Announces the Addition of Dr. Nurit Tweezer-Zaks to its Board of Directors

MISTRAS Group Inc (MG) Reports Q3 2023 Earnings: Revenue and Gross Profit Margin Increase Amid ...

GuruFocus.com

2 years ago

MISTRAS Group Inc (MG) Reports Q3 2023 Earnings: Revenue and Gross Profit Margin Increase Amid ...

Share on Social Networks: